Structure Info
- Chemspace ID
- CSSS00000036034 (In-Stock Screening Compounds)
- CAS
- 674-26-0
- MFCD
- MFCD00006648
- IUPAC Name
- 4-hydroxy-4-methyloxan-2-one
- Mol formula
- C6H10O3
- Mol weight
- 130 Da
- Catalog Number(s)
- 20348, 21625, 674-26-0, 96730, A119001834, A982863, AA003LFL, AB11003, AB67645, ACM-MO-674260, ACM503480, ACM674260, AG-30082, AG003LID, AJ67645, AOS003LID, AP674260, AR003M7D, AS-65830, BB4LS-BD2924, BBV-39688250, BD2924, C76125, C76125-0.25G, CD11074790, CM129733, CS-0030738, CSC000036034, D0587, D435230, D634400, F226574, FCH1116698, FM25990, HY-107855, I616, J60422, JH330454, JH462847, K139700, LN00196717, M-6700, M15570, M339025, M349025, R75133, SAB-033675, SC-53978, SM00664, SY032939, T1353, V153456, Y1045442, Y1266703, Y1483493, ZXC076914, ZXC332826
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -0.43
- Heavy atoms count
- 9
- Rotatable bond count
- 0
- Number of rings
- 1
- Carbon bond saturation, Fsp3
- 0.833
- Polar surface area (Å)
- 47
- Hydrogen bond acceptors count
- 2
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSSS00000036034
Items Overall 13 items from 4 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| MedChemExpress | 10 days | United States To: | 99 | 100 mg | 50 | |
| MedChemExpress | 10 days | United States To: | 99 | 250 mg | 100 | |
| MedChemExpress | 10 days | United States To: | 99 | 500 mg | 150 | |
| MedChemExpress | 10 days | United States To: | 99 | 10mM/1mL | 55 | |
Description: Names: DL-Mevalonolactone; (±)-Mevalonolactone; Mevalolactone; Product Description: DL-Mevalonolactone ((±)-Mevalonolactone;Mevalolactone) is the δ-lactone form of mevalonic acid, a precursor in the mevalonate pathway. DL-Mevalonolactone is orally active against HMGCR mutation and statin caused myopathy . DL-Mevalonolactone induces inflammation and oxidative stress response with decreased mitochondrial membrane potential (MMP) and induces mitochondrial swelling .; Target: Endogenous Metabolite; CAS: 674-26-0 | ||||||
| Key Organics Limited (BIONET) | 10 days | United Kingdom To: | 97 | 1 mg | 51 | |
| Key Organics Limited (BIONET) | 10 days | United Kingdom To: | 97 | 5 mg | 63 | |
| Key Organics Limited (BIONET) | 10 days | United Kingdom To: | 97 | 10 mg | 86 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 100 mg | 53 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 250 mg | 105 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 500 mg | 158 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 10mM/1mL | 58 | |
Description: Names: DL-Mevalonolactone; (±)-Mevalonolactone; Mevalolactone; Product Description: DL-Mevalonolactone ((±)-Mevalonolactone;Mevalolactone) is the δ-lactone form of mevalonic acid, a precursor in the mevalonate pathway. DL-Mevalonolactone is orally active against HMGCR mutation and statin caused myopathy DL-Mevalonolactone induces inflammation and oxidative stress response with decreased mitochondrial membrane potential (MMP) and induces mitochondrial swelling; Target: Endogenous Metabolite; CAS: 674-26-0 | ||||||
| Targetmol Chemicals Inc | 30 days | United States To: | 99 | 100 mg | 41 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 99 | 200 mg | 60 | |
Description: DL-Mevalonolactone, a human endogenous metabolite, is the δ-lactone form of mevalonate, a precursor of the mevalonate pathway. It reduces mitochondrial membrane potential (∆Ψm), Ca2 retention and NAD(P)H levels in the brain, and also induces mitochondrial swelling.DL-Mevalonolactone induces inflammation and oxidative stress, and reduces mitochondrial membrane potential.; CAS: 674-26-0 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire